# Cytokind Inc.

Canonical: https://abierto.us/vendors/cytokind-inc-esxsvjex6e33

- UEI: ESXSVJEX6E33
- CAGE: 8SF56
- Location: Exeter, NH
- Awards in window: 1 (1 transactions), -$604,585 obligated, January 16, 2024 to January 16, 2024

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, -$604,585

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$604,585

## Competition

- Competed Under SAP: 1 awards

## Largest awards

- 75A50122C00064 (definitive contract): -$604,585, Barda - Aspr / Daappo / Barda DCMA. Cytokind: the Overall Objective of This Contract Is to Provide Clinical Validation for the Treatment of Covid with NB-UVB Therapy. a Submission to the FDA for a New Indication Will Be Made.. https://www.usaspending.gov/award/CONT_AWD_75A50122C00064_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/cytokind-inc-esxsvjex6e33.